Skip to NavigationSkip to content

News

0
The collaboration will see the pair explore the enhanced efficacy in combining checkpoint inhibitors with a cancer stem cell-targeting antibody drug...
0
University of Sussex spearheads £6 million project funded by the Wellcome Trust and in collaboration with AstraZeneca
0
The company will now not seek approval for Revlimid (lenalidomide) in patients with diffuse large B-cell lymphoma who are responding to first-line...
0
A decline in sales of hepatitis C drugs such as Harvoni contributed to the fall in revenues

Features

A battle is raging for the soul of the pharma industry and the stakes are high.